SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-23-003420
Filing Date
2023-05-18
Accepted
2023-05-18 15:57:32
Documents
2
Period of Report
2023-05-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2229
2 POWER OF ATTORNEY exh_24.htm EX-24 5151
  Complete submission text file 0001171843-23-003420.txt   8748
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address
Kumar Amresh (Reporting) CIK: 0001978220 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 23935929